Weighing policy options for returning savings from site-neutral payment reforms to hospitals Benedic Ippolito, Matthew Fiedler, and Loren Adler Friday, May 26, 2023
Biden’s executive order on care work is an important step for an industry in crisis Molly Kinder Friday, May 5, 2023
2023 Apr 25 Past Event Graduate workshop: Health economics data and research from the Agency for Healthcare Research and Quality 1:00 PM - 5:00 PM EDT Online only
Comments on the Inflation Reduction Act Gerard F. Anderson and Richard G. Frank Monday, April 17, 2023
The health wedge and labor market inequality Amy Finkelstein, Casey McQuillan, Owen Zidar, and Eric Zwick Wednesday, March 29, 2023
Medicare Advantage spending, medical loss ratios, and related businesses: An initial investigation Richard G. Frank and Conrad Milhaupt Friday, March 24, 2023
Threats to Medicare’s new drug negotiation power Richard G. Frank and Len M. Nichols Wednesday, March 15, 2023
Drug shortages and IRA inflation rebates: Considerations for CMS Marta E. Wosińska Thursday, February 9, 2023
Nurse licensure compacts before, during, and after COVID Lauren Bauer, Aidan Creeron, Joy Dada, and Luiza Macedo Wednesday, February 8, 2023
Improving the effectiveness of public health efforts Matt Kasman and Ross A. Hammond Wednesday, February 1, 2023
Building resilience into US prescription drug supply chains Minje Park, Rena M. Conti, Marta E. Wosińska, Ergun Ozlem, Wallace J. Hopp, and Erin R. Fox Monday, January 30, 2023
Medicaid and Accelerated Approval: Spending on drugs with and without proven clinical benefits Rachel E. Sachs, Shelley A. Jazowski, Kyle A. Gavulic, Julie M. Donohue, and Stacie B. Dusetzina Wednesday, January 11, 2023
Reforming the Medicare Part D benefit design: Financial implications for beneficiaries, private plans, drug manufacturers, and the federal government Erin Trish, Katrina Kaiser, Jeanai Celestin, and Geoffrey Joyce Wednesday, January 11, 2023
Some drugs that improve price competition fall through the cracks of FDA user fees Marta E. Wosińska and Richard G. Frank Monday, December 12, 2022
Comments on the draft harmonized system code list of critical supply chains Marta E. Wosińska and Rena M. Conti Monday, November 7, 2022
The role of immigrants in the market for elder care Kristin F. Butcher, Kelsey Moran, and Tara Watson Friday, November 4, 2022
Multi-year Medicare physician fee freeze threatens access: Pair relief with reforms Paul B. Ginsburg and Steven M. Lieberman Wednesday, October 26, 2022
Insurers negotiate lower hospital prices for HIX than for commercial groups Samantha Randall, Erin Duffy, Sarah Green, and Erin Trish Wednesday, September 21, 2022
Auditing the prescription drug Consumer Price Index Richard G. Frank, Ernst R. Berndt, and Andrew L. Hicks Friday, August 26, 2022
Accelerated approval of cancer drugs: No economic reward for drug makers that conduct confirmatory trials Richard G. Frank, Ezekiel Emanuel, and Mahnum Shahzad Thursday, August 18, 2022
